Q4 2025 Perrigo Company PLC Earnings Call Transcript
Key Points
- Perrigo Co PLC (PRGO) achieved strong market share gains and secured over $100 million in new distribution and competitive takeaways.
- The company reported a 7% increase in EPS for the full year, aligning with revised guidance.
- Perrigo Co PLC (PRGO) made significant progress on its Three-S Plan, focusing on simplifying, streamlining, and strengthening the business.
- The innovation pipeline tripled in value compared to the previous year, indicating a robust future product lineup.
- The company is implementing a new operational enhancement program expected to deliver annualized pretax savings of $80 million to $100 million.
- The infant formula business continues to face structural challenges, affecting financials and outlook.
- Perrigo Co PLC (PRGO) experienced a decline in core organic net sales by 2% in the fourth quarter.
- The company recorded a goodwill impairment charge of $1.3 billion, reflecting historical business performance issues.
- Market conditions remain challenging, with OTC market consumption expected to remain negative in the first half of 2026.
- Perrigo Co PLC (PRGO) anticipates a significant EPS impact from plant under absorption due to lower sales volumes.
Good morning, ladies and gentlemen, and welcome to Perrigo Q4 2025 financial results conference call. (Operator Instructions) This call is being recorded on Thursday, February 26, 2026.
I would now like to turn the conference over to Bradley Joseph. Please go ahead.
Good morning, and good afternoon, everyone. Welcome to Perrigo's fourth quarter and full year 2025 earnings conference call. A copy of the release we issued this morning and the accompanying presentation for today's session are available within the Investors section of the perrigo.com website. Joining today's call are Perrigo's President and CEO; Patrick Lockwood-Taylor; and CFO, Eduardo Bezerra.
I'd like to remind everyone that during this presentation, participants will make certain forward-looking statements. Please refer to the slides for information regarding these statements, which are subject to important risks and uncertainties. We will reference adjusted financial measures that are non-GAAP in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

